Introduction Human papillomavirus (HPV) infection, which poses significant disease burden,
is decreasing following implementation of vaccination programs. Synthesized evidence on …

In 2018, there were an estimated 570,000 new cases of cervical cancer globally, with most
of them occurring in women who either had no access to cervical screening, or had not …

Background The introduction of primary HPV screening has doubled the number of
colposcopy referrals because of the direct referral of HPV-positive women with a borderline …

Background Shifting from cytology to human papillomavirus (HPV)-based cervical cancer
screening will initially increase colposcopy referrals. The anticipated impact on health …

This study presents a nonlinear deterministic mathematical model of Human Papillomavirus
(HPV) dynamics, emphasizing qualitative analysis through the stability theory of differential …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Cervical cancer is the fourth-leading cause of cancer deaths among women worldwide and
most cases occur in developing countries. Detection of high-risk (HR) HPV, the etiologic …

Simple Summary Testing for Human Papillomavirus (HPV) is currently being implemented
as part of cervical cancer (CC) screening in several countries. However, infections with all …

Background Human papillomavirus (HPV)-based screening programs still use one-size-fits-
all protocols but efficiency and efficacy of programs may be improved by stratifying women …

In a Norwegian pilot, triage of high-risk human papillomavirus (hrHPV)-positive women with
reflex cytology followed by hrHPV testing 12 months later, yielded 82% of women referred to …